Showing 1 - 10 of 121
Persistent link: https://www.econbiz.de/10003718171
Persistent link: https://www.econbiz.de/10010434769
Persistent link: https://www.econbiz.de/10003193758
Persistent link: https://www.econbiz.de/10002379705
The US Food and drug Administration (FDA) is estimated to regulate markets accounting for about 20% of consumer spending in the US. This paper proposes a general methodology to evaluate FDA policies, in general, and the central speed-safety tradeoff it faces, in particular. We apply this...
Persistent link: https://www.econbiz.de/10012466948
Persistent link: https://www.econbiz.de/10003588021
Persistent link: https://www.econbiz.de/10010434768
Persistent link: https://www.econbiz.de/10009236132
In the United States, drug safety and efficacy are primarily regulated by the Food and Drug Administration (FDA) and the legal system, which gives manufacturers large incentives to produce safe drugs and provide proper warnings for side effects, since patients can sue manufacturers that provide...
Persistent link: https://www.econbiz.de/10012465086
Congress enacted and renewed the Prescription Drug User Fee Acts (PDUFA) in 1992, and renewed it in 1997 and 2002, mandating FDA performance goals in reviewing and acting on drug applications within specified time periods. In turn, the FDA was permitted to levy user fees on drug sponsors...
Persistent link: https://www.econbiz.de/10012467867